Canada markets open in 2 hours 24 minutes

Cocrystal Pharma, Inc. (COCP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.4950+0.0500 (+3.46%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 15.21M
Enterprise Value -9.29M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.58
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.44

Trading Information

Stock Price History

Beta (5Y Monthly) 1.35
52-Week Change 3-39.52%
S&P500 52-Week Change 321.23%
52 Week High 33.2900
52 Week Low 31.3300
50-Day Moving Average 31.4948
200-Day Moving Average 31.9185

Share Statistics

Avg Vol (3 month) 314.34k
Avg Vol (10 day) 316.49k
Shares Outstanding 510.17M
Implied Shares Outstanding 610.17M
Float 87.11M
% Held by Insiders 130.03%
% Held by Institutions 16.72%
Shares Short (Mar 28, 2024) 44.96k
Short Ratio (Mar 28, 2024) 40.32
Short % of Float (Mar 28, 2024) 40.06%
Short % of Shares Outstanding (Mar 28, 2024) 40.05%
Shares Short (prior month Feb 29, 2024) 45.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 24, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Oct 11, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.68%
Return on Equity (ttm)-54.54%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -20.97M
Net Income Avi to Common (ttm)-17.98M
Diluted EPS (ttm)-1.8700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.35M
Total Cash Per Share (mrq)2.59
Total Debt (mrq)1.85M
Total Debt/Equity (mrq)7.02%
Current Ratio (mrq)8.92
Book Value Per Share (mrq)2.59

Cash Flow Statement

Operating Cash Flow (ttm)-14.67M
Levered Free Cash Flow (ttm)-10.01M